NCT04814719View on ClinicalTrials.gov

Treatment and Duration Effect of Pentosan Polysulfate Sodium (PPS) in Participants With Knee Osteoarthritis Pain

CompletedOBSERVATIONAL
Enrollment

133

Participants

Timeline

Start Date

June 24, 2023

Primary Completion Date

December 24, 2024

Study Completion Date

December 24, 2024

Conditions
Osteoarthritis, Knee
Interventions
DRUG

Pentosan Polysulphate Sodium

Subcutaneous Injection (100mg/ml)

DRUG

Placebo (Sodium Chloride Injection, 0.9%)

Placebo to match PPS

Trial Locations (2)

3124

Emeritus Research, Camberwell

60611

Northwestern University Feinberg School of Medicine, Chicago

Sponsors
All Listed Sponsors
lead

Paradigm Biopharmaceuticals Ltd.

INDUSTRY